Salacinol and related analogs: New leads for type 2 diabetes therapeutic candidates from the Thai traditional natural medicine Salacia chinensis

Nutrients

Volumn 7, Issue 3, 2015, Pages 1480-1493

  Morikawa, Toshio ^a   Akaki, Junji ^a,b   Ninomiya, Kiyofumi ^a   Kinouchi, Eri ^a   Tanabe, Genzoh ^a   Pongpiriyadacha, Yutana ^c   Yoshikawa, Masayuki ^a   Muraoka, Osamu ^a  

^a KINKI UNIVERSITY   (Japan)

^b Kobayashi Pharmaceutical Co   (Japan)

^c RAJAMANGALA UNIVERSITY OF TECHNOLOGY SRIVIJAYA   (Thailand)

Author keywords

Salacia chinensis; Type 2 diabetes therapeutic candidate; glucosidase inhibitor

Indexed keywords

ALPHA GLUCOSIDASE; HEMOGLOBIN A1C; KOTALANOL; NEOKOTALANOL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SALACIA CHINENSIS EXTRACT; SALACINOL; SULFONIUM DERIVATIVE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; GLYCOSIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; MONOSACCHARIDE; SUGAR ALCOHOL; SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG STABILITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; SALACIA; SALACIA CHINENSIS; STOMACH JUICE; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; HUMAN; METABOLISM; PHYTOTHERAPY; SMALL INTESTINE; SPRAGUE DAWLEY RAT;

MUS; RATTUS; SALACIA CHINENSIS;

ALPHA-GLUCOSIDASES; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GLYCOSIDE HYDROLASE INHIBITORS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTESTINE, SMALL; MALE; MICE; MONOSACCHARIDES; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SALACIA; SUGAR ALCOHOLS; SULFATES; SULFONIUM COMPOUNDS;

EID: 84924129937     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7031480     Document Type: Article

References (37)

1. Evert, A.B.; Boucher, J.L.; Cypress, M.; Dunbar, S.A.; Franz, M.J.; Mayer-Davis, E.J.; Neumiller, J.J.; Nwankwo, R.; Verdi, C.L.; Urbanski, P.; et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2013, 36, 3821-3842.
2. Perera, P.K.; Li, Y. Functional herbal food ingredients used in type 2 diabetes mellitus. Pharmacogn. Rev. 2012, 6, 37-45.
3. Jayaweera, D.M.A. Medicinal Plants in Ceylon Part. 1; National Science Council of Sri Lanka: Colombo, Sri Lanka, 1981; p. 77.
4. Vaidyartanam, P.S. In Indian Medicinal Plants: A Compendium of 500 Species; Warrier P.K., Nambiar, V.P.K., Ramankutty, C., Eds.; Orient Longman: Madras, India, 1993; pp. 47-48.
5. Chuakul, W.; Saralamp, P.; Paonil, W.; Temsiririkkul, R.; Clayton, T. Medicinal Plants in Thailand (Volume II); Department of Pharmaceutical Botany Faculty of Pharmacy, Mahidol University: Bangkok, Thailand, 1997; pp. 192-193.
6. Matsuda, H.; Yoshikawa, M.; Morikawa, T.; Tanabe, G.; Muraoka, O. Antidiabetogenic constituents from Salacia species. J. Trad. Med. 2005, 22, 145-153.
7. Yoshikawa, M.; Murakami, T.; Shimada, H.; Matsuda, H.; Yamahara, J.; Tanabe, G.; Muraoka, O. Salacinol, potent antidiabetic principle with unique thiosugar sulfonium sulfate structure from the Ayurvedic traditional medicine Salacia reticulata in Sri Lanka and India. Tetrahedron Lett. 1997, 38, 8367-8370.
8. Yoshikawa, M.; Morikawa, T.; Matsuda, H.; Tanabe, G.; Muraoka, O. Absolute stereostructure of potent α-glucosidase inhibitor, salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata. Bioorg. Med. Chem. 2002, 10, 1547-1554.
9. Tanabe, G.; Yoshikai, K.; Hatanaka, T.; Yamamoto, M.; Shao, Y.; Minematsu, T.; Muraoka, O.; Wang, T.; Matsuda, H.; Yoshikawa, M. Biological evaluation of de-O-sulfonated analogs of salacinol, the role of sulfate anion in the side chain on the α-glucosidase inhibitory activity. Bioorg. Med. Chem. 2007, 15, 3926-3937.
10. Tanabe, G.; Xie, W.; Ogawa, A.; Cao, C.; Minematsu, T.; Yoshikawa, M.; Muraoka, O. Facile synthesis of de-O-sulfated salacinols: Revision of the structure of neosalacinol, a potent α-glucosidase inhibitor. Bioorg. Med. Chem. Lett. 2009, 19, 2195-2198.
11. Yoshikawa, M.; Murakami, T.; Yashiro, K.; Matsuda, H. Kotalanol, a potent α-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic Ayurvedic medicine Salacia reticulata. Chem. Pharm. Bull. 1998, 46, 1339-1340.
12. Muraoka, O.; Xie, W.; Osaki, S.; Kagawa, A.; Tanabe, G.; Amer, M.F.A.; Minematsu, T.; Morikawa, T.; Yoshikawa, M. Characteristic alkaline catalyzed degradation of kotalanol, a potent α-glucosidase inhibitor isolated from Ayurvedic traditional medicine Salacia reticulata, leading to anhydroheptitols: Another structural proof. Tetrahedron 2010, 66, 3717-3722.
13. Muraoka, O.; Xie, W.; Tanabe, G.; Amer, M.F.A.; Minematsu, T.; Yoshikawa, M. On the structure of the bioactive constituent from Ayurvedic medicine Salacia reticulata: Revision of the literature. Tetrahedron Lett. 2008, 49, 7315-7317.
14. Yoshikawa, M.; Xu, F.; Nakamura, S.; Wang, T.; Matsuda, H.; Tanabe, G.; Muraoka, O. Salaprinol and ponkoranol with thiosugar sulfonium sulfate structure from Salacia prinoides and α-glucosidase inhibitory activity of ponkoranol and kotalanol desulfate. Heterocycles 2008, 75, 1397-1405.
15. Xie, W.; Tanabe, G.; Akaki, J.; Morikawa, T.; Ninomiya, K.; Minematsu, T.; Yoshikawa, M.; Wu, X.; Muraoka, M. Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors. Bioorg. Med. Chem. 2011, 19, 2015-2022.
16. Tanabe, G.; Sakano, M.; Minematsu, T.; Matsuda, H.; Yoshikawa, M.; Muraoka, O. Synthesis and elucidation of absolute stereochemistry of salaprinol, another thiosugar sulfonium sulfate from the Ayurvedic traditional medicine Salacia prinoides. Tetrahedron 2008, 64, 10080-10086.
17. Shimoda, H.; Kawamori, S.; Kawahara, Y. Effects of an aqueous extract of Salacia reticulata, a useful plant in Sri Lanka, on postprandial hyperglycemia in rats and humans. Nippon Eiyo Shokuryo Gakkaishi 1998, 151, 279-287.
18. Yoshikawa, M.; Pongpiriyadacha, Y.; Kishi, A.; Kageura, T.; Wang, T.; Morikawa, T.; Matsuda, H. Biological activities of Salacia chinensis originating in Thailand: The quality evaluation guided by α-glucosidase inhibitory activity. Yakugaku Zasshi 2003, 123, 871-880.
19. Beppu, H.; Kiuchi, Y.; Kishino, E.; Ito, T.; Fujita, K.; Shimpo, K.; Ozaki, S.; Chihara, T.; Itani, Y.; Sonoda, S.; et al. Effects of a hydrothermal extract of Salacia reticulata on oral saccharide tolerance tests in mice, rats and humans-Evaluations of the effects of a mixture with cyclodextrin on the hypoglycemic effect and variations in the blood glucose level in combination use of oral antidiabetic agents. J. JSMUFF 2005, 3, 25-30.
20. Oe, H.; Ozaki, S. Hypoglycemic effect of 13-membered ring thiocyclitol, a novel α-glucosidase inhibitor from Kothala-himbutu (Salacia reticulata). Biosci. Biotechnol. Biochem. 2008, 72, 1962-1964.
21. Kajimoto, O.; Kawamori, S.; Shimoda, H.; Kawahara, Y.; Hirata, H.; Takahashi, T. Effects of a diet containing Salacia reticulata on mild type 2 diabetes in humans: A placebo-controlled, cross-over trial. Nippon Eiyo Shokuryo Gakkaishi 2000, 53, 199-205.
22. Shimoda, H.; Fujimura, T.; Makino, K.; Yoshijima, K.; Naito, K.; Ihota, H.; Miwa, Y. Safety profile of extractive from trunk of Salacia reticulata (Celastraceae). J. Food Hyg. Soc. Jpn. 1999, 40, 198-205.
23. Williams, J.A.; Choe, Y.S.; Noss, M.J.; Baumgartner, C.J.; Mustad, V.A. Extract of Salacia oblonga lowers acute glycemia in patients with type 2 diabetes. Am. J. Clin. Nutr. 2007, 86, 124-130.
24. Kobayashi, M.; Akaki, J.; Yamashita, K.; Morikawa, T.; Ninomiya, K.; Yoshikawa, M.; Muraoka, O. Suppressive effect of the tablet containing Salacia chinensis extract on postprandial blood glucose. Jpn. Pharmacol. Ther. 2010, 38, 545-550.
25. Tanimura, C.; Terada, I.; Hiramatu, K.; Ikeda, T.; Kasagi, T.; Kishino, E.; Ito, T.; Fujita, K. Effect of a mixture of aqueous extract from Salacia reticulata (Kotala himbutu) and cyclodextrin on the serum glucose and the insulin levels in sucrose tolerance test and on serum glucose level changes and gastro-intestinal disorder by massive ingestion. Yonago Igaku Zasshi 2005, 56, 85-93.
26. Jihong, Y.; Shaozhong, L.; Jingfeng, S.; Kobayashi, M.; Akaki, J.; Yamashita, K.; Tamesada, M.; Umemura, T. Effects of Salacia chinensis extract on reproductive outcome in rats. Food Chem. Toxicol. 2011, 49, 57-60.
27. Muraoka, O.; Morikawa, T.; Miyake, S.; Akaki, J.; Ninomiya, K.; Yoshikawa, M. Quantitative determination of potent α-glucosidase inhibitors, salacinol and kotalanol, in Salacia species using liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52, 770-773.
28. Akaki, J.; Morikawa, T.; Miyake, S.; Ninomiya, K.; Okada, M.; Tanabe, G.; Pongpiriyadacha, Y.; Yoshikawa, O.; Muraoka, O. Evaluation of Salacia species as anti-diabetic natural resources based on quantitative analysis of eight sulphonium constituents: A new class of α-glucosidase inhibitors. Phytochem. Anal. 2014, 25, 544-550.
29. Muraoka, O.; Morikawa, T.; Miyake, S.; Akaki, J.; Ninomiya, K.; Pongpiriyadacha, Y.; Yoshikawa, M. Quantitative analysis of neosalacinol and neokotalanol, another two potent α-glucosidase inhibitors from Salacia species, by LC-MS with ion pair chromatography. J. Nat. Med. 2011, 65, 142-148.
30. Nakamura, K.; Akaki, J.; Ishibushi, F.; Tani, K.; Morikawa, T.; Pongpiriyadacha, Y.; Muraoka, O.; Hayakawa, T.; Kakutani, K. Discrimination of genus Salacia plants based on the DNA sequence of the internal transcribed spacer region. Shoyakugaku Zasshi 2015, submitted.
31. Kashiwagi, A.; Kasuga, M.; Araki, E.; Oka, Y.; Hanafusa, T.; Hiroshi, I.; Tominaga, M.; Oikawa, S.; Noda, M.; Kawamura, T.; et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan diabetes society to national glycohemoglobin standardization program Valu. J. Diabetes Investig. 2012, 3, 39-40.
32. Morikawa, T.; Ninomiya, K.; Imamura, M.; Akaki, J.; Fujikura, S.; Pan, Y.; Yuan, D.; Yoshikawa, M.; Jia, X.; Li, Z.; et al. Acylated phenylethanoid glycosides, echinacoside and acteoside from Cistanche. tubulosa, improve glucose tolerance in mice. J. Nat. Med. 2014, 68, 561-566.
33. Wang, Y.; Sun, G.; Sun, J.; Liu, S.; Wang, J.; Xu, X.; Miao, L. Spontaneous type 2 diabetic rodent models. J. Diabetes Res. 2013, 2013, 401723, doi:10.1155/2013/401723.
34. Nasi, R.; Patrick, B.O.; Sim, L.; Rose, D.R.; Pinto, B.M. Studies directed toward the stereochemical structure determination of the naturally occurring glucosidase inhibitor, kotalanol: Synthesis and inhibitory activities against human maltase glucoamylase of seven-carbon, chain-extended homologues of salacinol. J. Org. Chem. 2008, 73, 6172-6181.
35. Mohan, S.; Pinto, B.M. Towards the elusive structure of kotalanol, a naturally occurring glucosidase inhibitor. Nat. Prod. Rep. 2010, 27, 481-488.
36. Sim, L.; Jayakanthan, K.; Mohan, S.; Nasi, R.; Johnston, B.D.; Pinto, B.M.; Rose, D.R. New glucosidase inhibitors from an Ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata. Biochemistry 2010, 49, 443-451.
37. Mohan, S.; Eskandari, R.; Pinto, B.M. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: A promising class of potential antidiabetic agents. Acc. Chem. Res. 2014, 47, 211-225.